Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Leukemia 23Leukemia, Myeloid, Acute 9Congenital Abnormalities 7Leukemia, Megakaryoblastic, Acute 6Leukemia, Myelomonocytic, Acute 5Leukemia, Monocytic, Acute 5Leukemia, Erythroblastic, Acute 5Lymphoma 3Melanoma 2Leukemia, Promyelocytic, Acute 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leukemia, Eosinophilic, Acute 2Leukemia, Basophilic, Acute 2HIV Infections 2Unspecified Adult Solid Tumor, Protocol Specific 1Precancerous Conditions 1Papillomavirus Infections 1Neuroblastoma 1Myelodysplastic Syndromes 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphohistiocytosis, Hemophagocytic 1Lung Neoplasms 1Leukemia, Myeloid, Chronic-Phase 1Kidney Neoplasms 1Hodgkin Disease 1Epstein-Barr Virus Infections 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Immunoenzyme Techniques 3Docetaxel 3N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide 2Immunohistochemistry 2AEG 35156 2temsirolimus 1sabarubicin 1halofuginone 1Trabectedin 1SB939 compound 1Reverse Transcriptase Polymerase Chain Reaction 1N-(6-chlorophenoxyhexyl)-N''-cyano-N''-4-pyridylguanidine 1Mass Spectrometry 1Immunologic Techniques 1Flow Cytometry 1Fenretinide 1Chromatography, Liquid 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Unspecified Adult Solid Tumor, Protocol Specific × Flow Cytometry × Clear all
NCT00372736 2023-08-04

AEG35156 and Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Solid Tumors

Canadian Cancer Trials Group

Phase 1 Completed
27 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡